We further investigated the presence of cytotoxic CD4+ T cells and HLA-II-expressing tumor cells in treatment-naive NSCLC samples using immunofluorescence (Fig. 4d, Supplementary Fig. 7). This evidence concerns the gene CD4 and neoplasm.